Ozelle Brings AI-Powered, Scenario-Ready Diagnostics to WHX Labs Dubai 2026

DUBAI, UAE, Jan. 23, 2026 /PRNewswire/ -- Ozelle, a global innovator in intelligent diagnostics, will showcase its next-generation solution at WHX Labs Dubai 2026 (Feb 10–13, Booth S1.D58). Under the theme "AI × CBM: The Next-Generation of Complete Blood Morphology," Ozelle will highlight how diagnostic testing can evolve beyond standalone analyzers toward intelligent, scenario-ready solutions designed to bridge the gap between lab-grade precision and real-world clinical environments.

AI × CBM: See More. Diagnose Smarter.

Ozelle's AI-powered Complete Blood Morphology (CBM) redefines hematology diagnostics by combining high-resolution imaging with real-time algorithmic analysis. Moving beyond traditional numerical data, the system identifies multi-classified cells—including NST, NSG, ALY, and RET—enabling earlier detection and more informed clinical decisions from a single drop of blood.

All-in-One Testing: Scenario-Driven, Flexible Panels

The solution integrates hematology, biochemistry, and immunoassay into a single, maintenance-free workflow. Clinicians can build flexible, on-demand panels tailored to specific scenarios: Infection typing (CBC+CRP+SAA), Diabetes care (CBC+HbA1c), and Cardiac screening (CBC+NT-proBNP), among others. This versatility empowers primary care clinics and pharmacies to deliver comprehensive results with unmatched efficiency.

Intelligent AI Workbench: From Results to Diagnostic Guidance

A key highlight at WHX Labs Dubai will be Ozelle's Intelligent AI Workbench (Open Dx), a unified diagnostic workbench built directly into the analyzer. The system seamlessly integrates test ordering, result review, and AI-assisted guidance into a single workflow, enabling clinicians to move efficiently from testing to interpretation with greater confidence.

The workbench transforms traditional static reports into interactive diagnostic insights by automatically identifying abnormal findings, flagging potential risks, and providing structured overview interpretations. Through conversational AI functionality, clinicians can further explore results via interactive report consultation. In veterinary applications, the AI Workbench also supports AI-assisted diagnostic guidance and medication references tailored specifically to animal care.

Global Scale, Validated Precision

Ozelle's AI capabilities are anchored by 50,000+ installations worldwide, generating over 50 million cell images daily. This database, exceeding 100 billion real-world data points, ensures continuously refined algorithms validated through an industry-exclusive quality control system.

Ozelle invites all attendees to WHX Labs Dubai (Booth S1.D58) for live demonstrations and interactive sessions to experience how AI × CBM is shaping the future of diagnostic testing. Leave a message to secure your meeting and experience it live. 

Contact Ozelle

www.ozellemed.com

info@ozellepoct.com

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Ozelle Brings AI-Powered, Scenario-Ready Diagnostics to WHX Labs Dubai 2026

HEFEI, China, Jan. 23, 2026 /PRNewswire/ -- Sungrow, a globally renowned renewable energy company, has been named on Corporate Knights' 2026 Global 100 list of the world's most sustainable corporations during the World Economic Forum in Davos. Ranked 12^th globally and first in the electrical equipment manufacturing sector, the recognition highlights Sungrow's sustainable growth strategy and strong business performance.

For the 2026 ranking, the Global 100 evaluated more than 8,000 publicly listed companies based on criteria including sustainable investments, revenues, and revenue momentum. This accolade follows Sungrow's recent recognition by Time magazine and Statista as one of the World's Best Companies in Sustainable Growth 2026.

Sustainability Embedded in Strategy and Operations

Guided by its sustainability philosophy, "Green Mission, Better Life," Sungrow actively integrates the principles into every facet of its global operations. The company's strategic framework is built on five pillars: Excellent Governance, Towards Net Zero, Eco-friendly Development, Mutually Beneficial Collaboration, and Diversity and Inclusion. This commitment has been recognized with an MSCI ESG rating of AAA and the EcoVadis Gold Medal for Corporate Social Responsibility at the group level in 2025.

Sungrow is also committed to achieving carbon neutrality on the operational level by 2028, carbon neutrality across the supply chain by 2038, and net zero across the supply chain by 2048.

Innovation as the Bridge to a Sustainable Future

Sungrow's sustainability impact is driven by continuous innovation and R&D investment. In the first three quarters of 2025 alone, the company invested USD 438 million in research and development with more than 11,000 patents filed. This technological expertise supports its "Bridge to a Sustainable Future" brand value proposition, converting natural resources into reliable clean energy for customers in over 100 countries.

By the end of June 2025, Sungrow's cumulative installed capacity of power electronic converters exceeded 870 GW worldwide, over 540 million tons of CO₂ emissions can be avoided annually together with its customers. The company continues to advance comprehensive solutions across solar, wind, energy storage, EV charging, and hydrogen energy.

About Sungrow

Sungrow, a global leader in renewable energy technology, has pioneered sustainable power solutions for over 29 years. As of June 2025, Sungrow has installed 870 GW of power electronic converters worldwide and is recognized by BloombergNEF as the world's most bankable PV inverter and energy storage company. Sungrow supports customers with a global service network of 520 service outlets. For more information, please visit: www.sungrowpower.com/en.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Sungrow Ranks 12th Globally and Tops Electrical Equipment Sector in Corporate Knights' 2026 Global 100